HEALTH CANADA AUTHORIZES LILLY’S KISUNLA™ (DONANEMAB), A NEW …
CNW/ – Today, after more than 35 years of commitment to advancing Alzheimer’s research, Lilly Canada announced Health Canada’s approval of …Read More
CNW/ – Today, after more than 35 years of commitment to advancing Alzheimer’s research, Lilly Canada announced Health Canada’s approval of …Read More
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
by Newsbot · Published May 6, 2026
